✦ LIBER ✦

Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group

✍ Scribed by Andrea Koch; Bengt Bergman; Erik Holmberg; Christer Sederholm; Lars Ek; Jaroslaw Kosieradzki; Kristina Lamberg; Lars Thaning; Sven-Olof Ydreborg; Sverre Sörenson

Book ID: 116430730
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 504 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2011.03.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine versus gemcitabine/carboplat

Gemcitabine versus gemcitabine/carboplatin in advanced non–small cell lung cancer: Preliminary findings in a phase III trial of the Swedish Lung Cancer Study Group

✍ Christer Sederholm 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Role of recombinant interferon-gamma mai

Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase iii study of the eortc lung cancer cooperative group

✍ N.van Zandwijk; H.J.M. Groen; P.E. Postmus; J.Th.W. Burghouts; G.P.M. ten Velde; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 812 KB

Temozolomide in patients with advanced n

Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases: a phase II study of the EORTC Lung Cancer Group (08965)

✍ R Dziadziuszko; A Ardizzoni; P.E Postmus; E.F Smit; A Price; C Debruyne; C Legra 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Vinorelbine plus gemcitabine followed by

Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study

✍ Kaoru Kubota; Masaaki Kawahara; Mitsumasa Ogawara; Yutaka Nishiwaki; Kiyoshi Kom 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 173 KB

Docetaxel Versus Docetaxel/Cisplatin in

Docetaxel Versus Docetaxel/Cisplatin in Patients with Advanced Non–Small-Cell Lung Cancer: Preliminary Analysis of a Multicenter, Randomized Phase III Study

✍ V. Georgoulias; A.G. Pallis; C. Kourousis; A. Alexopoulos; A. Ardavanis; A. Agel 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 150 KB

Quality of life in patients with advance

Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study

✍ Chandra P Belani; Thomas Brodowicz; Tudor E Ciuleanu; Maciej Krzakowski; Sung Hy 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 230 KB